World's Best Scientists 2026 revealed!
James B. Leverenz

James B. Leverenz

D-Index & Metrics

Neuroscience

D-Index
107
Citations
51804
World Ranking
600
National Ranking
340

James B. Leverenz publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where James B. Leverenz sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 405 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

James B. Leverenz D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where James B. Leverenz sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 107 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

James B. Leverenz is affiliated with the Cleveland Clinic in the United States, focusing their research primarily within the field of Medicine. Their work spans several specialized subfields, including Neurology, Psychiatry and Mental Health, Physiology, Molecular Biology, and Immunology.

The core topics addressed in their research include:

  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Parkinson's Disease Mechanisms and Treatments
  • Bioinformatics and Genomic Networks
  • Tryptophan and brain disorders
  • Inflammation biomarkers and pathways

Leverenz has contributed to numerous publications in notable venues. Their frequent publication outlets include:

  • Alzheimer's & Dementia
  • Neurology
  • Alzheimer's Research & Therapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Alzheimer's Disease

Leverenz has collaborated extensively with several co-authors, including:

  • Jagan A. Pillai
  • Lynn M. Bekris
  • Feixiong Cheng
  • Andrew A. Pieper
  • Jeffrey L. Cummings

Their recent published papers reflect ongoing engagement with neurodegenerative disorders and cognitive conditions. Notable recent works include:

  • Research criteria for the diagnosis of prodromal dementia with Lewy bodies, 2020, Neurology
  • Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium, 2020, Newcastle University ePrints (Newcastle University)
  • LATE-NC staging in routine neuropathologic diagnosis: an update, 2022, Acta Neuropathologica
  • Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment, 2021, Alzheimer's Research & Therapy
  • Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial, 2021, Alzheimer's & Dementia

Best Publications

  • Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

    Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday

  • Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

    Peter T Nelson;Irina Alafuzoff;Eileen H Bigio;Constantin Bouras

  • Analysis of shared heritability in common disorders of the brain

    Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters

  • The Parkinson Progression Marker Initiative (PPMI)

    Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf

  • Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

    Suzanne Craft;Laura D. Baker;Thomas J. Montine;Satoshi Minoshima

  • Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.

    Dennis W Dickson;Heiko Braak;John E Duda;Charles Duyckaerts

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis

    Vivianna M. Van Deerlin;James B. Leverenz;James B. Leverenz;Lynn M. Bekris;Thomas D. Bird;Thomas D. Bird

  • DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

    Zhen Hong;Min Shi;Kathryn A. Chung;Joseph F. Quinn

  • Research criteria for the diagnosis of prodromal dementia with Lewy bodies

    Ian G. McKeith;Tanis J. Ferman;Alan J. Thomas;Frédéric Blanc

  • TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models

    Taylor R. Jay;Crystal M Miller;Paul J Cheng;Leah C Graham

  • DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers

    C. F. Lippa;J. E. Duda;M. Grossman;H. I. Hurtig

  • Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

    Osama Sabri;Marwan N. Sabbagh;John Seibyl;Henryk Barthel

  • Neuropathologic substrates of Parkinson disease dementia.

    David J. Irwin;Matthew T. White;Jon B. Toledo;Sharon X. Xie

  • Neuropathological and Genetic Correlates of Survival and Dementia Onset in Synucleinopathies: A Retrospective Analysis

    David J Irwin;Murray Grossman;Daniel Weintraub;Daniel Weintraub;Howard I Hurtig

  • Clinico-Neuropathological Correlation of Alzheimer's Disease in a Community-Based Case Series

    Alfredo Lim;Debby Tsuang;Walter Kukull;David Nochlin

  • Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

    Hanae Nakashima-Yasuda;Kunihiro Uryu;John Robinson;Sharon X. Xie

  • Pathological correlates of dementia in a longitudinal, population-based sample of aging

    Joshua A. Sonnen;Eric B. Larson;Paul K. Crane;Sebastien Haneuse

  • Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression.

    Min Shi;Joshua Bradner;Aneeka M. Hancock;Kathryn A. Chung

  • Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings

    Paul K. Crane;Laura E. Gibbons;Kristen Dams-O’Connor;Emily Trittschuh

  • Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders

    Fadi Abdi;Joseph F. Quinn;Joseph Jankovic;Martin McIntosh

Frequent Co-Authors

Thomas J. Montine
Thomas J. Montine Stanford University
Cyrus P. Zabetian
Cyrus P. Zabetian University of Washington
Elaine R. Peskind
Elaine R. Peskind University of Washington
Joseph F. Quinn
Joseph F. Quinn Oregon Health & Science University
Douglas Galasko
Douglas Galasko University of California, San Diego
Thomas D. Bird
Thomas D. Bird University of Washington
Murray A. Raskind
Murray A. Raskind University of Washington
Gerard D. Schellenberg
Gerard D. Schellenberg University of Pennsylvania
John Q. Trojanowski
John Q. Trojanowski University of Pennsylvania
Jeffrey Kaye
Jeffrey Kaye Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education can open up new doors for students interested in neuroscience and related fields. Many aspiring professionals now consider stacking their credentials through online certificate programs that pay well, allowing them to build specialized skills and improve their employability—often in less time than it takes to earn a traditional degree.

For those seeking a streamlined academic path, looking into the easiest degree to get online can help accelerate entry into the workforce and reduce educational expenses. Complementing a neuroscience background with interdisciplinary training, such as behavioral health or social work, can also be beneficial.

Notably, related fields such as mental health and behavioral analysis offer in-demand online programs. Professionals interested in social impact may consider msw programs online, focusing on social work and counseling. Meanwhile, aspiring specialists in applied behavioral analysis can look into the bcba masters programs to enhance their career prospects.

By combining neuroscience with these related degrees and certifications, students can unlock a range of career pathways and meet today’s diverse workforce needs.

Best Scientists Citing James B. Leverenz

Trending Scientists